SCHEMBL16258491

SCHEMBL16258491

Cc1nc2ccccc2c(I)c1[C@H](OC(C)(C)C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.48
▸ PSIP1 O75475 1/20 0.48
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.40
▸ HTT P42858 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NUDT1 P36639 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ GPR3 P46089 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10157230 1.00 CYP3A4 (0.48) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL10157239 0.89 MEN1 (0.45) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL10157235 0.88 MEN1 (0.43) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL13269047 0.85 CYP3A4 (0.48) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL10157257 0.83 PSIP1 (0.43) CYP3A4PSIP1NR1I2
SCHEMBL10157172 0.80 GPR3 (0.37) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL29985665 0.79 CYP3A4 (0.59) CYP3A4PSIP1MEN1KMT2AGAA
SCHEMBL15416377 0.78 PSIP1 (0.41) CYP3A4PSIP1NR1I2
SCHEMBL12877159 0.78 MEN1 (0.39) CYP3A4PSIP1MEN1KMT2AHSD17B10
SCHEMBL30887308 0.78 PSIP1 (0.57) CYP3A4PSIP1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2757096-A9 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-11-26 — — EP disclosed
Send feedback